379 related articles for article (PubMed ID: 17202264)
1. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.
McMullen JR; Amirahmadi F; Woodcock EA; Schinke-Braun M; Bouwman RD; Hewitt KA; Mollica JP; Zhang L; Zhang Y; Shioi T; Buerger A; Izumo S; Jay PY; Jennings GL
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):612-7. PubMed ID: 17202264
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Kang PM; Izumo S
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12355-60. PubMed ID: 14507992
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
[TBL] [Abstract][Full Text] [Related]
5. Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.
Pretorius L; Du XJ; Woodcock EA; Kiriazis H; Lin RC; Marasco S; Medcalf RL; Ming Z; Head GA; Tan JW; Cemerlang N; Sadoshima J; Shioi T; Izumo S; Lukoshkova EV; Dart AM; Jennings GL; McMullen JR
Am J Pathol; 2009 Sep; 175(3):998-1009. PubMed ID: 19679877
[TBL] [Abstract][Full Text] [Related]
6. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
7. The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.
Weeks KL; Bernardo BC; Ooi JYY; Patterson NL; McMullen JR
Adv Exp Med Biol; 2017; 1000():187-210. PubMed ID: 29098623
[TBL] [Abstract][Full Text] [Related]
8. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
9. PI3K(p110alpha) inhibitors as anti-cancer agents: minding the heart.
McMullen JR; Jay PY
Cell Cycle; 2007 Apr; 6(8):910-3. PubMed ID: 17404510
[TBL] [Abstract][Full Text] [Related]
10. PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.
Lin RC; Weeks KL; Gao XM; Williams RB; Bernardo BC; Kiriazis H; Matthews VB; Woodcock EA; Bouwman RD; Mollica JP; Speirs HJ; Dawes IW; Daly RJ; Shioi T; Izumo S; Febbraio MA; Du XJ; McMullen JR
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):724-32. PubMed ID: 20237330
[TBL] [Abstract][Full Text] [Related]
11. Exercise training alters left ventricular geometry and attenuates heart failure in dahl salt-sensitive hypertensive rats.
Miyachi M; Yazawa H; Furukawa M; Tsuboi K; Ohtake M; Nishizawa T; Hashimoto K; Yokoi T; Kojima T; Murate T; Yokota M; Murohara T; Koike Y; Nagata K
Hypertension; 2009 Apr; 53(4):701-7. PubMed ID: 19255362
[TBL] [Abstract][Full Text] [Related]
12. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.
Luo J; McMullen JR; Sobkiw CL; Zhang L; Dorfman AL; Sherwood MC; Logsdon MN; Horner JW; DePinho RA; Izumo S; Cantley LC
Mol Cell Biol; 2005 Nov; 25(21):9491-502. PubMed ID: 16227599
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.
McMullen JR; Shioi T; Huang WY; Zhang L; Tarnavski O; Bisping E; Schinke M; Kong S; Sherwood MC; Brown J; Riggi L; Kang PM; Izumo S
J Biol Chem; 2004 Feb; 279(6):4782-93. PubMed ID: 14597618
[TBL] [Abstract][Full Text] [Related]
14. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure.
Yu P; Zhang Y; Li C; Li Y; Jiang S; Zhang X; Ding Z; Tu F; Wu J; Gao X; Li L
J Cell Mol Med; 2015 Jul; 19(7):1710-9. PubMed ID: 25851780
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice.
Sagara S; Osanai T; Itoh T; Izumiyama K; Shibutani S; Hanada K; Yokoyama H; Yamamoto Y; Yokota T; Tomita H; Magota K; Okumura K
J Hypertens; 2012 Apr; 30(4):778-86. PubMed ID: 22306848
[TBL] [Abstract][Full Text] [Related]
16. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
[TBL] [Abstract][Full Text] [Related]
17. Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.
Song HK; Kim J; Lee JS; Nho KJ; Jeong HC; Kim J; Ahn Y; Park WJ; Kim DH
PLoS One; 2015; 10(3):e0122251. PubMed ID: 25826393
[TBL] [Abstract][Full Text] [Related]
18. The protective effects of exercise and phosphoinositide 3-kinase (p110alpha) in the failing heart.
Owen KL; Pretorius L; McMullen JR
Clin Sci (Lond); 2009 Mar; 116(5):365-75. PubMed ID: 19175355
[TBL] [Abstract][Full Text] [Related]
19. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
[TBL] [Abstract][Full Text] [Related]
20. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Dorfman AL; Longnus S; Pende M; Martin KA; Blenis J; Thomas G; Izumo S
Mol Cell Biol; 2004 Jul; 24(14):6231-40. PubMed ID: 15226426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
